The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group

Haematologica

Volumn 92, Issue 10, 2007, Pages 1381-1388

  Locatelli, Franco ^a   Zecca, Marco ^a   Pession, Andrea ^b   Morreale, Giuseppe ^c   Longoni, Daniela ^d   Di Bartolomeo, Paolo ^e   Porta, Fulvio ^f   Fagioli, Franca ^g   Nobili, Bruno ^h   Bernardo, Maria Ester ^a   Messina, Chiara ⁱ  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e Ospedale di Pescara   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

Author keywords

Fanconi anemia; Fludarabine; Hematopoietic stem cell transplantation; Unrelated donor

Indexed keywords

FLUDARABINE;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PROBABILITY; SURVIVAL RATE; T CELL DEPLETION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ITALY; MALE; PROBABILITY; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 36348964259     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11436     Document Type: Article

References (39)

1. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, eds. Hematology of Infancy and Childhood. Philadelphia: W.B. Saunders Co.; 2003:280-95.
2. Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, et al. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group. Blood 2000;96:4064-70.
3. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi's anemia. Blood 2003;101:822-6.
4. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249-56.
5. Gluckman E, Auerbach AD, Horowitz MH, Sobocinski KA, Ash RC, Bortin MM, et al. Bone marrow transplantation for Fanconi anemia. Blood 1995;86:2856-62.
6. Socié G, Devergie A, Girinski T, Piel G, Ribaud F, Esperou H, et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998;103:249-55.
7. Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.
8. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983;54:431-40.
9. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 1999; 24:849-52.
10. Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JC, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000;95:422-9.
11. de La Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IA, Rahemtulla A, et al. Non TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2004; 34:95.
12. Wagner JE, Eapen M, Macmillan ML, Harris RE, Pasquini R, Boulad F, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109:2256-62.
13. Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J, et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000; 111:1153-7.
14. McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IA, Dokal I. Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. Br J Haematol 2001; 112:427-9.
15. de Medeiros CR, Silva LM, Pasquini R. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001;28:110-2.
16. Rossi G, Giorgiani G, Comoli P, Nobili B, Salvaneschi L, De Stefano P, et al. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. Bone Marrow Transplant 2003;31:437-40.
17. Dufour C, Rondelli R, Locatelli F, Miano M, Di Girolamo G, Bacigalupo A, et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP)-Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 2001; 112:796-805.
18. Dini G, Lanino E, Lamparelli T, Barbanti M, Sacchi N, Carcassi C, et al. Unrelated donor marrow transplantation initial experience of the Italian bone marrow transplant group (GITMO). Bone Marrow Transplant 1996;17:55-62.
19. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socié G, Maury S, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005;36:947-50.
20. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18: 295-304.
21. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplantation from HLA-identical siblings. Ann Intern Med 1983;98:461-6.
22. Gooley TA, Leisenring W, Crowley JA, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18:665-706.
23. Fine JP, Gray RJ. A proportional hazards model for sub distribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
24. de Medeiros CR, Bitencourt MA, Zanis-Neto J, Maluf EC, Carvalho DS, Bonfim CS, et al. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution. Braz J Med Biol Res 2006; 39:1297-304.
25. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998;92:3515-20.
26. Locatelli F, Zecca M, Messina C, Rondelli R, Lanino E, Sacchi N, et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 2002; 16:2228-37.
27. Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997;89:4531-6.
28. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic disease. Blood 1998;91:756-63.
29. Socié G, Scieux C, Gluckman E, Soussi T, Clavel C, Saulnier P, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anaemia: further evidence of a multistep process. Transplantation 1998; 66:667-70.
30. Millen FJ, Rainey MG, Hows JM, Burton PA, Irvine GH, Swirsky D. Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia. Br J Haematol 1997;99:410-4.
31. Rosenberg PS, Socié G, Alter BP, Gluckman E. Risk of head and neck squamous cell carcinoma and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005;105:67-73.
32. Ringdén O, Labopin M, Gorin NC, et al. Bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004;22:416-23.
33. Fagnoni FF, Oliviero B, Giorgiani G, et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 2004;104:281-289.
34. Volpi I, Perruccio K, Tosti A, et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 2001;97:2514-21.
35. Mielkarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998;91:215-222.
36. Liu L, Rich BE, Inobe J, Chen W, Weiner HL. Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol 1998; 8:1017-26.
37. Puccetti P, Romani L, Bistoni F. A Th1-Th2-like switch in candidiasis: new perspective for therapy. Trends Microbiol 1995;3:237-240.
38. Cenci E, Mencacci A, Fé d'Ostiani C, et al. Cytokine- and T-helper-dependent immunity in murine aspergillosis. Res Immunol 1998;149:445-454.
39. Locatelli F, Comoli P, Montagna D, Rossi F, Daudt L, Maccario R. Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2004;17:479-92.